Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
476,756
-
Share change
-
+70,866
-
Total reported value
-
$4,429,000
-
Price per share
-
$9.24
-
Number of holders
-
10
-
Value change
-
+$658,000
-
Number of buys
-
2
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q4 2019
As of 31 Dec 2019,
Scinai Immunotherapeutics Ltd. - ADSs (BVXV) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
476,756 shares.
The largest 10 holders included
Ibex Investors LLC, Mariner, LLC, BANK HAPOALIM BM, HighTower Advisors, LLC, RENAISSANCE TECHNOLOGIES LLC, LADENBURG THALMANN FINANCIAL SERVICES INC., ROYAL BANK OF CANADA, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, and RMR Wealth Builders.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.